Ratan Tata says rumours about his health unfounded; was undergoing age-related medical investigations
The Hindu
Ratan Tata addresses rumors about his health, assures public he is undergoing routine medical investigations at 86.
Ratan Tata, chairman emeritus of the Tata Group, said on Monday (October 7, 2024) that he was undergoing age-related medical investigations and that rumours circulating about his health were unfounded.
"There is no cause for concern. I remain in good spirits," Mr. Tata, 86, said in posts on social media and in a statement released on his behalf.
Equity indices Sensex and Nifty drop amid foreign fund outflows and Fed rate cut concerns, impacting market trends.
Kia India introduces the Syros compact SUV, targeting a premium audience with advanced features and safety technology.
Indian stock market plunges as Sensex and Nifty tumble amid global sell-off and foreign fund outflows, hitting record lows.
Air India orders 34 trainer aircraft for new flying training school in Amravati, set to open in 2025.
Indian rupee hits record low of 85.08 against USD as Fed signals cautious monetary policy, impacting emerging market currencies.
SpiceJet settles $16 million dispute with Genesis, paying $6 million and offering $4 million stake in airline.
Nestle India unaffected by suspension of MFN status between India and Switzerland, maintaining 10% withholding tax on cross-country payments.
New Zealand's economy plunges into recession, prompting aggressive rate cuts and a sharp decline in GDP.
Indian footwear sector aims for $26 billion market by 2030, focusing on self-sufficiency, innovation, and quality under government support.
SEBI extends suspension of farm commodity futures trading to January 31, 2025, impacting NCDEX and MCX.
Sensex and Nifty plummet due to US Federal Reserve's indication of fewer rate cuts, leading to global market decline.